Shanghai Pharmaceuticals Holding Co., Ltd's latest marketcap:
As of 06/21/2025, Shanghai Pharmaceuticals Holding Co., Ltd's market capitalization has reached $8.12 B. According to our data, Shanghai Pharmaceuticals Holding Co., Ltd is the 2210th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | 8.12 B |
Revenue (ttm) | 38.4 B |
Net Income (ttm) | 604.59 M |
Shares Out | 3.71 B |
EPS (ttm) | 0.16 |
Forward PE | 13.23 |
Ex-Dividend Date | 09/24/2024 |
Earnings Date | 08/26/2025 |
Shanghai Pharmaceuticals Holding Co., Ltd's yearly market capitalization.
Date | Market Cap | Change (%) | Global Rank |
---|---|---|---|
06/21/2025 | ¥8.12 B | -15.78% | 2210 |
12/31/2024 | ¥69.4 B | 23.68% | 1785 |
12/29/2023 | ¥56.11 B | -6.6% | 1993 |
12/30/2022 | ¥60.07 B | 21.91% | 1690 |
12/31/2021 | ¥49.28 B | 3.76% | 2239 |
12/31/2020 | ¥47.49 B | -0.6% | 2101 |
12/31/2019 | ¥47.78 B | 4.62% | 1849 |
12/28/2018 | ¥45.67 B | -23.89% | 1607 |
12/29/2017 | ¥60.01 B | 20.48% | 1399 |
12/30/2016 | ¥49.81 B | 1.54% | 1389 |
Company Profile
Shanghai Pharmaceuticals Holding Co., Ltd.
Overview: Shanghai Pharmaceuticals Holding Co., Ltd. is a leading pharmaceutical and healthcare company engaged in research, development, manufacturing, distribution, and retailing of medical products across China and internationally.
Business Segments
- Production: Manufactures pharmaceuticals and healthcare products.
- Distribution: Provides pharmaceutical supply chain solutions.
- Retail: Operates a network of retail pharmacy stores.
- Others: Includes additional healthcare-related services.
Product Portfolio
The company offers a diverse range of products, including:
- Chemicals and biochemicals
- Chinese medicines
- Healthcare products
- Medical devices
Therapeutic Areas
Shanghai Pharmaceuticals serves multiple therapeutic areas, such as:
- Cardiovascular and endocrinology
- Oncology and anti-tumor treatments
- Neurological and autoimmune disorders
- Respiratory and digestive system conditions
- Anti-inflammatory and antiviral solutions
Additional Services
The company provides:
- Pharmaceutical distribution and warehousing
- Logistics and supply chain solutions
- Value-added services for hospitals and pharmacies
Founded: 1994
Headquarters: Shanghai, China
Frequently Asked Questions
-
What is Shanghai Pharmaceuticals Holding Co., Ltd's (SHA-601607) current market cap?As of 06/21/2025, Shanghai Pharmaceuticals Holding Co., Ltd (including the parent company, if applicable) has an estimated market capitalization of $8.12 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Shanghai Pharmaceuticals Holding Co., Ltd (SHA-601607) rank globally by market cap?Shanghai Pharmaceuticals Holding Co., Ltd global market capitalization ranking is approximately 2210 as of 06/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.